Search hospitals > Mississippi > Pascagoula
Singing River Hospital
Claim this profilePascagoula, Mississippi 39581
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
91 reported clinical trials
2 medical researchers
Summary
Singing River Hospital is a medical facility located in Pascagoula, Mississippi. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Singing River Hospital is involved with conducting 91 clinical trials across 167 conditions. There are 2 research doctors associated with this hospital, such as James E. Clarkson and Michael A. Finan.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
James E. ClarksonSinging River Hospital9 years of reported clinical research
Studies Cancer
Studies Breast Cancer
5 reported clinical trials
13 drugs studied
Michael A. FinanSinging River Hospital6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
3 reported clinical trials
7 drugs studied
Clinical Trials running at Singing River Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
ALK Gene Rearrangement
Brain Metastasis
Tumors
Cardiotoxicity
HER2 Positive
Cancer
Progesterone Receptor Positive
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Singing River Hospital?
Singing River Hospital is a medical facility located in Pascagoula, Mississippi. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Singing River Hospital is involved with conducting 91 clinical trials across 167 conditions. There are 2 research doctors associated with this hospital, such as James E. Clarkson and Michael A. Finan.